ABSTRACT: Sexually transmitted infections remain a public health concern in BC. Rates of gonorrhea and chlamydia have been increasing over the past decade. Similarly, the incidence of syphilis in BC has been increasing, particularly in men who have sex with men, but also in women aged 15 to 49 years. This rise has prompted new […]
Sexually transmitted infections in British Columbia: An update Read More »
Blue and Goldcast · Episode 36 Julio Montaner Dr. Julio Montaner is the director of the British Columbia Center for Excellence in HIV/AIDS, the chair in AIDS research and head of the division of AIDS in the faculty of medicine at the University of British Columbia. He discusses highlights of his distinguished career as one
Episode 36: Julio Montaner – Bringing Passion and Energy to HIV/AIDS research Read More »
As the Omicron wave wanes, people across the U.S. are welcoming reprieve from a virus that has killed nearly 1 million Americans and hospitalized millions more. But as recent articles in The New York Times, The Atlantic, and other outlets have pointed out, the threat of Covid-19 still looms large for millions of Americans who
To Prevent Future Variants, We Must Protect Those Most at Risk Read More »
66 cases have been identified in the province so far and experts fear it is more transmissible than the original strain. A new sub-lineage of the Omicron coronavirus variant is spreading across Europe at a concerning rate and 66 cases have been identified so far in B.C. Scientists and health officials around the world are keeping their
Brazil survey finds only 15% of men who have sex with men who qualify for free PrEP are using it Research from Brazil suggests that men who have sex with men are more likely to use PrEP (pre-exposure prophylaxis) if they have a good level of HIV knowledge and have positive feelings about homosexuality. What
Stigma and a lack of HIV knowledge linked to low PrEP use Read More »
The use of an opioid is common among people living with the human immunodeficiency virus (HIV; PLWH) and affects HIV outcomes harshly. The effect of the initiation of buprenorphine (BUP) on subsequent HIV viral loads was evaluated for a study. PLWH from the Johns Hopkins HIV Clinical Cohort was recognized who started BUP between 2002
Human Immunodeficiency Virus Viral Suppression Being Impacted By Buprenorphine Read More »
Continuing our partnership with STORYHIVE — a platform which supports BC and Alberta-based creators — we interviewed Calgary-based filmmaker, Laura O’Grady, about her latest film. Undetectable is an award-winning short documentary exploring what has prevented us from living in a world free of HIV/AIDS. If you’d like to check out other filmmakers we’ve profiled in this
Undetectable: An Interview with Director Laura O’Grady Read More »
La científica lleva adelante el desarrollo de anticuerpos monoclonales contra el covid en Gran Bretaña. Esto nos dijo. “El Ómicron recolectó las mejores mutaciones de Alfa, Beta, Gama, Theta Lambda, Mu y las juntó todas. Hizo una selección ventajosa. Es más o menos lo que contó Darwin hace siglos, donde hay una ventaja adaptativa. Entonces,
On December 1st we celebrate World AIDS Day, an opportunity to reflect on our challenges and successes four decades into the battle against HIV/AIDS. Around the world there are nearly 38 million people living with HIV and about 1.5 million new infections per year. A recent report by the World Health Organization estimates the number
BC’s success story shows strength of Treatment as Prevention Read More »
The 11th International AIDS Society (IAS) Conference on HIV Science took place from July 18th to the 21st and BC-CfE researchers attending the virtual conference used the opportunity to present their latest findings. Taking place virtually from Berlin, IAS 2021 saw around 6,000 participants and opened with remarks from German Chancellor Angela Merkel and included
BC-CfE researchers attend world’s most influential meeting on HIV research Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
